Here's Why Investors Should Retain ResMed (RMD) Stock for Now
https://www.zacks.com/stock/news/2228766/here-s-why-investors-should-retain-resmed-rmd-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2228766
Feb 20, 2024 - Investors are optimistic about ResMed's (RMD) increased adoption of AirSense10 and AirSense11 devices.
0
Turning 73 in 2024? It's Time to Get Ready for Your First RMD.
https://www.fool.com/retirement/2024/04/14/turning-73-in-2024-its-time-to-get-ready-for-your/?source=iedfolrf0000001
Apr 14, 2024 - It's important to know the rules of RMDs so you can plan accordingly and avoid penalties.
0
Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down
https://seekingalpha.com/news/4089446-needham-sees-bsx-cnmd-rmd-beating-street-despite-medtech-slow-down?source=feed_sector_healthcare
Apr 14, 2024 - Needham estimates Q1 medtech sales grew less than expected, but that Boston Scientific, CONMED, ResMed and Surmodics should still be able to beat the Street. Read more here.
0
Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank
https://www.fool.com/investing/2024/04/17/why-eli-lilly-stock-beat-the-market-today-while-re/?source=iedfolrf0000001
Apr 17, 2024 - The company published some very good news from the lab, although it wasn't so encouraging for smaller rivals.
0
Are Medical Stocks Lagging OrganiGram (OGI) This Year?
https://www.zacks.com/stock/news/2263262/are-medical-stocks-lagging-organigram-ogi-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-2263262
Apr 26, 2024 - Here is how OrganiGram (OGI) and ResMed (RMD) have performed compared to their sector so far this year.
0
Why ResMed (RMD) is a Top Growth Stock for the Long-Term
https://www.zacks.com/stock/news/2221023/why-resmed-rmd-is-a-top-growth-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_growth_score-2221023
Feb 05, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
0
ResMed (RMD) to Treat Sleep Apnea With New AirCurve 11 Device
https://www.zacks.com/stock/news/2225610/resmed-rmd-to-treat-sleep-apnea-with-new-aircurve-11-device?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2225610
Feb 13, 2024 - ResMed's (RMD) new AirCurve11 series incorporates myAir and AirView digital health apps to provide maximum comfort and support during therapy.
0
ResMed (RMD) to Treat Sleep Apnea With New AirCurve 11 (Revised)
https://www.zacks.com/stock/news/2227458/resmed-rmd-to-treat-sleep-apnea-with-new-aircurve-11-revised?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2227458
Feb 16, 2024 - ResMed's (RMD) new AirCurve11 series incorporates MyAir and AirView digital health apps to provide maximum comfort and support during therapy.
0
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
https://www.zacks.com/stock/news/2238061/are-you-a-momentum-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2238061
Mar 08, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
0
Here's Why Investors Should Buy ResMed (RMD) Stock Now
https://www.zacks.com/stock/news/2248659/here-s-why-investors-should-buy-resmed-rmd-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2248659
Apr 01, 2024 - Investors are optimistic about ResMed (RMD) led by the strong uptake of the myAir app with Air 11 systems.
0
Pages: 12
Page 1